The information provided on this website is intended expressly for healthcare professionals within the US
Please select one of the following:
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
©2025 Bayer. All rights reserved. BAYER, the Bayer Cross, and KERENDIA are registered trademarks of Bayer. All other trademarks are the property of their respective owners. Last updated 09/25.
You are encouraged to report side effects or quality complaints of products to the FDA by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088.
References:
- Kerendia (finerenone) [prescribing information]. Whippany, NJ: Bayer HealthCare Pharmaceuticals, Inc; July 2025.
- Greene SJ, et al. JAMA Cardiol. 2025;10(5):407-408. doi:10.1001/jamacardio.2025.0038
- Shahid I, et al. Heart Fail Rev. 2025;30(3):515-523. doi:10.1007/s10741-025-10481-7
- Blazek O. Am Heart J Plus. 2022;19:100187. doi:10.1016/j.ahjo.2022.100187
- American Diabetes Association Professional Practice Committee. Diabetes Care. 2025;48(suppl 1):S207-S238. doi:10.2337/dc25-S010
- American Diabetes Association Professional Practice Committee. Diabetes Care. 2025;48(suppl 1):S239-S251. doi:10.2337/dc25-S011
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. Kidney Int. 2024;105(4S):S117-S314. doi:10.1016/j.kint.2023.10.018
- de Boer IH, et al. Diabetes Care. 2022;45(12):3075-3090. doi:10.2337/dci22-0027
- Blonde L, et al. Endocr Pract. 2022;28(10):923-1049. doi:10.1016/j.eprac.2022.08.002
- McDonagh TA, et al. Eur Heart J. 2023;44(37):3627-3639. doi:10.1093/eurheartj/ehad195
- Marx N, et al. Eur Heart J. 2023;44(39):4043-4140. doi:10.1093/eurheartj/ehad192
- Agarwal R, et al. Eur Heart J. 2022;43(6):474-484. doi:10.1093/eurheartj/ehab777
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. Kidney Suppl. 2013;3(1):1-150. doi:10.1038/kisup.2012.73
- Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. Kidney Int. 2020;98(4S):S1-S115. doi:10.1016/j.kint.2020.06.019
- Alicic RZ, et al. Clin J Am Soc Nephrol. 2017;12(12):2032-2045. doi:10.2215/CJN.11491116
- Ameer OZ. Front Pharmacol. 2022;13:949260. doi:10.3389/fphar.2022.949260
- Burnier M, et al. Circ Res. 2023;132(8):1050-1063. doi:10.1161/CIRCRESAHA.122.321762
- Chaudhuri A, et al. Diabetes Obes Metab. 2022;24(3):365-376. doi:10.1111/dom.14601
- Alicic RZ, et al. Adv Chronic Kidney Dis. 2018;25(2):181-191. doi:10.1053/j.ackd.2017.12.002
- An J, et al. BMJ Open Diabetes Res Care. 2021;9(1):e001847. doi:10.1136/bmjdrc-2020-001847
- Cade WT. Phys Ther. 2008;88(11):1322-1335. doi:10.2522/ptj.20080008
- Kolkhof P, et al. Pharmacol Res. 2021;172:105859. doi:10.1016/j.phrs.2021.105859
- Kolkhof P, et al. Handb Exp Pharmacol. 2017;243:271-305. doi:10.1007/164_2016_76
- Pitt B, et al. N Engl J Med. 2021;385(24):2252-2263. doi:10.1056/NEJMoa2110956
- Bakris GL, et al; FIDELIO-DKD Investigators. N Engl J Med. 2020;383(23):2219-2229. doi:10.1056/NEJMoa2025845
- Morales J, et al. Clin Diabetes. 2023;41(4):553-566. doi:10.2337/cd22-0110
- Writing Group for the CKD Prognosis Consortium, et al. JAMA. 2023;330(13):1266-1277. doi:10.1001/jama.2023.17002
- Rossing P, et al. Am J Med. 2022;135(5):576-580. doi:10.1016/j.amjmed.2021.11.019
- Raghavan S, et al. J Am Heart Assoc. 2019;8(4):e011295. doi:10.1161/JAHA.118.011295
- Stamler J, et al. Diabetes Care. 1993;16(2):434-444. doi:10.2337/diacare.16.2.434
- An Y, et al. Diabetes Care. 2015;38(7):1365-1371. doi:10.2337/dc14-2498
- Haffner SM, et al. N Engl J Med. 1998;339(4):229-234. doi:10.1056/NEJM199807233390404
- Scirica BM, et al. JAMA Cardiol. 2018;3(2):155-163. doi:10.1001/jamacardio.2017.4228
- McGill JB, et al. BMJ Open Diabetes Res Care. 2022;10(4):e002806. doi:10.1136/bmjdrc-2022-002806
- Ruilope LM, et al. Nephrol Dial Transplant. 2023;38(2):372-383. doi:10.1093/ndt/gfac157
- Kovesdy CP, et al. Nephron. 2025;149(7):371-383. doi:10.1159/000543923
- Aldactone (spironolactone) [prescribing information]. New York, NY: Pfizer; March 2018.
- Inspra (eplerenone) [prescribing information]. New York, NY: Pfizer; May 2016.
- Kolkhof P. Mol Cell Endocrinol. 2012;350(2):310-317. doi:10.1016/j.mce.2011.06.025
- Upadhyay A, et al. Clin Diabetes. 2024;43(1):43-52. doi:10.2337/cd24-0036
- Data on file, Bayer. As of July 2025.